Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Management of Severe Hyperglycemia

Initial Assessment

  • The American Diabetes Association recommends evaluating for signs of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar state (HHS) by checking serum ketones, arterial pH, bicarbonate, osmolality, and mental status 1
  • Assess for dehydration, which is typically more severe in HHS (9 liters or 100-200 ml/kg total body water deficit) compared to DKA 1
  • Identify potential precipitating factors including infection, missed insulin doses, medications (corticosteroids, diuretics, beta-blockers), or intercurrent illness 2, 3
  • Monitor for altered mental status, which may indicate cerebral edema, a rare but potentially fatal complication 4

Fluid Therapy

  • The American College of Physicians recommends beginning aggressive fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 ml/kg/hour during the first hour to restore circulatory volume and tissue perfusion 1
  • Target correction of estimated fluid deficits within the first 24 hours, with induced change in serum osmolality not exceeding 3 mOsm/kg/h 1

Insulin Therapy

  • Administer an intravenous bolus of regular insulin at 0.15 U/kg body weight, followed by a continuous infusion at 0.1 U/kg/h, as recommended by the American Association of Clinical Endocrinologists 1
  • If plasma glucose does not fall by 50 mg/dL from initial value in the first hour, double the insulin infusion rate every hour until a steady glucose decline between 50-75 mg/h is achieved 1

Electrolyte Management

  • Monitor and replace potassium, as total body deficits in hyperglycemic crises typically include 4-6 mEq/kg of potassium, according to the American Heart Association 1
  • Once renal function is assured and serum potassium is known, add 20-40 mEq/L potassium to the infusion 1

Complications to Monitor

  • Watch for hypoglycemia due to overzealous insulin treatment, as warned by the American Diabetes Association 4
  • Monitor for hypokalemia due to insulin administration and treatment of acidosis, as cautioned by the American College of Cardiology 4
  • Be alert for signs of cerebral edema, including lethargy, behavioral changes, seizures, incontinence, pupillary changes, bradycardia, and respiratory arrest, as advised by the American Academy of Neurology 1

Prevention of Recurrence

  • Provide education on sick-day management, including when to contact healthcare providers, blood glucose goals, supplemental insulin use during illness, and maintaining hydration, as recommended by the American Diabetes Association 4
  • Emphasize the importance of never discontinuing insulin during illness, as stressed by the American Association of Clinical Endocrinologists 4